Camber Spine reported 4Q17 revenue growth +54.2% vs. 4Q16, and 2017 growth +46.0% vs. 2016. The increase was attributed largely to 97% growth of active surgeon users in the past 12 months.
Product launches from 2017 included the Ti-Diagon™ Anatomic Oblique TLIF, SPIRA™ Open Matrix ALIF (shown below) and the SPIRA-C™ Open Matrix Cervical Interbody. The SPIRA line is the company’s first series built with 3D printing/additive techniques.
In 2018, the company expects FDA clearance of six new products and will launch next-gen iterations of the ENZA™ MIS ALIF, SPIRA™-L Open Architecture Lateral Cage and SPIRA™V Open Matrix Corpectomy devices.
Camber Spine reported 4Q17 revenue growth +54.2% vs. 4Q16, and 2017 growth +46.0% vs. 2016. The increase was attributed largely to 97% growth of active surgeon users in the past 12 months.
Product launches from 2017 included the Ti-Diagon™ Anatomic Oblique TLIF, SPIRA™ Open Matrix ALIF (shown below) and the SPIRA-C™ Open Matrix Cervical...
Camber Spine reported 4Q17 revenue growth +54.2% vs. 4Q16, and 2017 growth +46.0% vs. 2016. The increase was attributed largely to 97% growth of active surgeon users in the past 12 months.
Product launches from 2017 included the Ti-Diagon™ Anatomic Oblique TLIF, SPIRA™ Open Matrix ALIF (shown below) and the SPIRA-C™ Open Matrix Cervical Interbody. The SPIRA line is the company’s first series built with 3D printing/additive techniques.
In 2018, the company expects FDA clearance of six new products and will launch next-gen iterations of the ENZA™ MIS ALIF, SPIRA™-L Open Architecture Lateral Cage and SPIRA™V Open Matrix Corpectomy devices.
Copy to clipboard 
